<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated">
      <PMID Version="1">35193047</PMID>
      <DateCompleted>
        <Year>2022</Year>
        <Month>03</Month>
        <Day>24</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2022</Year>
        <Month>03</Month>
        <Day>24</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1532-2661</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>145</Volume>
            <PubDate>
              <Year>2022</Year>
              <Month>Jul</Month>
            </PubDate>
          </JournalIssue>
          <Title>Research in veterinary science</Title>
          <ISOAbbreviation>Res Vet Sci</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Establishment and transcriptome characterization of tamoxifen-resistant canine mammary gland tumor cells.</ArticleTitle>
        <Pagination>
          <StartPage>135</StartPage>
          <EndPage>146</EndPage>
          <MedlinePgn>135-146</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1016/j.rvsc.2022.02.018</ELocationID>
        <ELocationID EIdType="pii" ValidYN="Y">S0034-5288(22)00055-8</ELocationID>
        <Abstract>
          <AbstractText>Tamoxifen (TAM) currently is still the drug of choice for endocrine therapy in patients with estrogen receptor positive breast cancer. However, the development of drug resistance not only limits the drug utilization, but also greatly reduces the survival of patients. At the same time, TAM is poorly understood in canine mammary gland tumors. Therefore, it is crucial to find effective methods to reverse drug resistance and prevent the development of drug resistance so as to improve the efficacy of endocrine therapy for breast cancer. Firstly, we successfully established two TAM-resistant canine mammary gland tumor cells lines including TAMp,TAMm by drug concentration gradient plus drug maintenance, and then we confirmed that the resistant cells have stronger proliferation, migration, invasion and cloning ability by CCK8, Wound healing assay, Transwell invasion assay and Clone formation assay. Second, we performed sequencing analysis of TAMm and CHMm and detected a large number of different expression genes, including reported and novel drug-resistant genes, and genes involved in complex biological processes. Finally, we explored the role of the classical Wnt signaling pathway in drug-resistant cells, and immunofluorescence and western blot results showed increased expression of Wnt pathway related genes β-catenin and P-GSK3β in drug-resistant cells, indicating abnormal activation of the classical Wnt/β-catenin pathway This study successfully established two TamR cell lines and assayed its resistance generation in many aspects, which provides a good experimental model and theoretical support for a more comprehensive understanding of the endocrine drug resistance mechanism.</AbstractText>
          <CopyrightInformation>Copyright © 2022 The Authors. Published by Elsevier Ltd.. All rights reserved.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Xu</LastName>
            <ForeName>EnShuang</ForeName>
            <Initials>E</Initials>
            <AffiliationInfo>
              <Affiliation>College of Animal Science and Veterinary Medicine, Heilongjiang Bayi Agricultural University, Daqing 163319, China; Department of Veterinary Surgery, College of Veterinary Medicine, Northeast Agricultural University, Key Laboratory of Comparative Medicine, Harbin, Heilongjiang 150030, PR China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Guan</LastName>
            <ForeName>Tongxu</ForeName>
            <Initials>T</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Veterinary Surgery, College of Veterinary Medicine, Northeast Agricultural University, Key Laboratory of Comparative Medicine, Harbin, Heilongjiang 150030, PR China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Hu</LastName>
            <ForeName>MengXin</ForeName>
            <Initials>M</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Veterinary Surgery, College of Veterinary Medicine, Northeast Agricultural University, Key Laboratory of Comparative Medicine, Harbin, Heilongjiang 150030, PR China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Tong</LastName>
            <ForeName>Danning</ForeName>
            <Initials>D</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Veterinary Surgery, College of Veterinary Medicine, Northeast Agricultural University, Key Laboratory of Comparative Medicine, Harbin, Heilongjiang 150030, PR China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Ge</LastName>
            <ForeName>RuiDong</ForeName>
            <Initials>R</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Veterinary Surgery, College of Veterinary Medicine, Northeast Agricultural University, Key Laboratory of Comparative Medicine, Harbin, Heilongjiang 150030, PR China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Liu</LastName>
            <ForeName>Yun</ForeName>
            <Initials>Y</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Veterinary Surgery, College of Veterinary Medicine, Northeast Agricultural University, Key Laboratory of Comparative Medicine, Harbin, Heilongjiang 150030, PR China. Electronic address: abliuyun@yeah.net.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2022</Year>
          <Month>02</Month>
          <Day>12</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>England</Country>
        <MedlineTA>Res Vet Sci</MedlineTA>
        <NlmUniqueID>0401300</NlmUniqueID>
        <ISSNLinking>0034-5288</ISSNLinking>
      </MedlineJournalInfo>
      <ChemicalList>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D018931">Antineoplastic Agents, Hormonal</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>094ZI81Y45</RegistryNumber>
          <NameOfSubstance UI="D013629">Tamoxifen</NameOfSubstance>
        </Chemical>
      </ChemicalList>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D018931" MajorTopicYN="N">Antineoplastic Agents, Hormonal</DescriptorName>
          <QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName>
          <QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D001943" MajorTopicYN="Y">Breast Neoplasms</DescriptorName>
          <QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName>
          <QualifierName UI="Q000662" MajorTopicYN="N">veterinary</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D045744" MajorTopicYN="N">Cell Line, Tumor</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D049109" MajorTopicYN="N">Cell Proliferation</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D004283" MajorTopicYN="Y">Dog Diseases</DescriptorName>
          <QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName>
          <QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D004285" MajorTopicYN="N">Dogs</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D019008" MajorTopicYN="N">Drug Resistance, Neoplasm</DescriptorName>
          <QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D015972" MajorTopicYN="N">Gene Expression Regulation, Neoplastic</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D061986" MajorTopicYN="N">MCF-7 Cells</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D013629" MajorTopicYN="N">Tamoxifen</DescriptorName>
          <QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D059467" MajorTopicYN="N">Transcriptome</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D060449" MajorTopicYN="N">Wnt Signaling Pathway</DescriptorName>
        </MeshHeading>
      </MeshHeadingList>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">Canine mammary gland tumors</Keyword>
        <Keyword MajorTopicYN="N">Tamoxifen-resistant</Keyword>
        <Keyword MajorTopicYN="N">Transcriptome sequencing</Keyword>
        <Keyword MajorTopicYN="N">Wnt singling pathway</Keyword>
        <Keyword MajorTopicYN="N">Wnt3</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2021</Year>
          <Month>4</Month>
          <Day>26</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="revised">
          <Year>2021</Year>
          <Month>12</Month>
          <Day>28</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2022</Year>
          <Month>2</Month>
          <Day>9</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2022</Year>
          <Month>2</Month>
          <Day>23</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2022</Year>
          <Month>3</Month>
          <Day>25</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2022</Year>
          <Month>2</Month>
          <Day>22</Day>
          <Hour>20</Hour>
          <Minute>11</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">35193047</ArticleId>
        <ArticleId IdType="doi">10.1016/j.rvsc.2022.02.018</ArticleId>
        <ArticleId IdType="pii">S0034-5288(22)00055-8</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
</PubmedArticleSet>
